ABBV vs. JNJ
Compare and contrast key facts about AbbVie Inc. (ABBV) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABBV or JNJ.
Correlation
The correlation between ABBV and JNJ is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ABBV vs. JNJ - Performance Comparison
Key characteristics
ABBV:
0.64
JNJ:
-0.07
ABBV:
0.95
JNJ:
0.01
ABBV:
1.15
JNJ:
1.00
ABBV:
0.82
JNJ:
-0.06
ABBV:
1.91
JNJ:
-0.16
ABBV:
8.15%
JNJ:
7.10%
ABBV:
24.58%
JNJ:
16.24%
ABBV:
-45.09%
JNJ:
-52.60%
ABBV:
-8.94%
JNJ:
-11.34%
Fundamentals
ABBV:
$324.98B
JNJ:
$368.05B
ABBV:
$2.86
JNJ:
$5.77
ABBV:
64.30
JNJ:
26.37
ABBV:
0.41
JNJ:
0.96
ABBV:
$41.23B
JNJ:
$66.30B
ABBV:
$30.76B
JNJ:
$45.96B
ABBV:
$17.62B
JNJ:
$22.61B
Returns By Period
In the year-to-date period, ABBV achieves a 4.46% return, which is significantly lower than JNJ's 5.21% return. Over the past 10 years, ABBV has outperformed JNJ with an annualized return of 16.33%, while JNJ has yielded a comparatively lower 6.96% annualized return.
ABBV
4.46%
4.46%
-1.14%
13.74%
22.94%
16.33%
JNJ
5.21%
5.21%
-5.85%
-0.88%
3.27%
6.96%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ABBV vs. JNJ — Risk-Adjusted Performance Rank
ABBV
JNJ
ABBV vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ABBV vs. JNJ - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 3.42%, more than JNJ's 3.23% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 3.42% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
JNJ Johnson & Johnson | 3.23% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
Drawdowns
ABBV vs. JNJ - Drawdown Comparison
The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum JNJ drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for ABBV and JNJ. For additional features, visit the drawdowns tool.
Volatility
ABBV vs. JNJ - Volatility Comparison
AbbVie Inc. (ABBV) has a higher volatility of 7.58% compared to Johnson & Johnson (JNJ) at 6.73%. This indicates that ABBV's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ABBV vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities